• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans
  • .org
  • Districts
  • Media
  • SupportUs
  • Collaborate
  • Contact
  • Search
  • Join


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

BioTime Inc.

Started by caliban , Mar 25 2011 01:11 AM
economics regenerative medicine stemells tissue engineering regmed

  • Please log in to reply
777 replies to this topic

#271 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 24 May 2013 - 04:29 AM

BioTime Announces Results of Vote at Special Meeting of Shareholders
Business Wire (press release) - 15 hours ago
BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today announced that at a Special Meeting held on May 21, 2013, its shareholders approved the proposals related to the planned acquisition of stem cell related assets from Geron Corporation by BioTime's ...

View the full article

#272 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 31 May 2013 - 02:52 AM

Dr. Robert N. Butler Appointed to Board of Directors of BioTime, Inc.
EON: Enhanced Online News (press release) - 9 hours ago
ALAMEDA, Calif.--(EON:Enhanced Online News)--BioTime, Inc. (OTCBB:BTIM) announced today that Robert N. Butler, M.D., has been elected to BioTime's Board of Directors.

View the full article

#273 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 31 May 2013 - 07:00 AM

BioTime, Inc. Adds New Members to Its Board of Directors
EON: Enhanced Online News (press release) - 9 hours ago
EON: Enhanced Online News)--BioTime, Inc. (OTCBB: BTIM) announced today that it has expanded its Board of Directors to include four new members, Neal C. Bradsher, Arnold I. Burns, Abraham E. Cohen, and Alfred D. Kingsley.

View the full article

sponsored ad

  • Advert

#274 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 01 June 2013 - 11:39 AM

BioTime Asia, Limited and Shanghai Genext Medical Technology Co., Ltd. Sign ...
EON: Enhanced Online News (press release) - 22 hours ago
EON: Enhanced Online News)--BioTime Asia, Limited, a subsidiary of BioTime, Inc. (NYSE Amex:BTX) today announced an agreement with Shanghai Genext Medical Technology Co.

View the full article

#275 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 04 June 2013 - 05:03 AM

CLVS Zooms To New High, FLML Gets Thumbs Up, SNTA Dives, STEM Grows
RTT News - 2 hours ago
BioTime Inc. (BTX: Quote) has offered to sell up to an aggregate of 2,180,016 common shares and 545,004 warrants to purchase common shares, in "units" with each unit consisting of one common share and one-quarter of a warrant, at an offering price of ...

View the full article

#276 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 06 June 2013 - 10:00 PM

BioTime Set to Join Russell 3000 Index
EON: Enhanced Online News (press release) - 4 hours ago
ALAMEDA, Calif.--(EON: Enhanced Online News)--BioTime, Inc. (NYSE Amex:BTIM) announced today that it has been included on a preliminary list of additions to the Russell 3000® Index and Russell Global® Index posted by Russell Investments on June 11 ...

View the full article

#277 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 07 June 2013 - 01:29 PM

BioTime, Inc. Closes on $9 Million Financing
The Herald | HeraldOnline.com - 13 hours ago
ALAMEDA, Calif. - BioTime, Inc. (NYSE MKT: BTX) today announced that it has closed the equity financing it announced on June 3, 2013 and received gross proceeds of $9,057,966.

View the full article

#278 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 17 June 2013 - 12:43 PM

BioTime CEO Dr. Michael West to Ring The Opening Bell at the New York Stock ...
EON: Enhanced Online News (press release) - 8 hours ago
EON: Enhanced Online News)--BioTime, Inc. (NYSE Amex:BTIM) Chief Executive Officer Michael D. West, Ph.D. will ring The Opening Bell at the New York Stock Exchange at 9:30 a.m.

View the full article

#279 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 12 June 2013 - 12:55 AM

BioTime Names Robert W. Peabody Senior Vice President and Chief Operating ...
EON: Enhanced Online News (press release) - Jun 12, 2013
(EON:Enhanced Online News)--BioTime, Inc. (OTCBB:BTIM) today announced that Robert W. Peabody, CPA, has joined BioTime as Senior Vice President and Chief Operating Officer.

View the full article

#280 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 11 June 2013 - 10:38 PM

BioTime, Inc. to Present Plans for Regenerative Medicine at Acumen BioFin ...
EON: Enhanced Online News (press release) - Jun 11, 2013
EMERYVILLE, Calif.--(EON:Enhanced Online News)--BioTime, Inc. (OTCBB:BTIM) today announced that Michael D. West, Ph.

View the full article

#281 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 12 June 2013 - 01:01 PM

BioTime Appoints Henry L. Nordhoff to Board of Directors
Business Wire (press release) - Jun 12, 2013
BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today announced that Henry L. Nordhoff, former CEO and Chairman of Gen-Probe Inc., has been appointed to its Board of Directors.

View the full article

#282 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 16 July 2013 - 01:05 PM

BioTime CEO Dr. Michael West to Present at the Case Western Reserve ...
EON: Enhanced Online News (press release) - 8 hours ago
BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, announced that Chief Executive Officer Michael D. West, PhD will present today at the Case Western ...

View the full article

#283 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 17 July 2013 - 03:57 AM

BioTime CEO Dr. Michael West to Present at the Case Western Reserve ...
DailyFinance - 7 hours ago
(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, announced that Chief Executive Officer Michael D. West, PhD will present today at the Case Western ...

View the full article

#284 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 16 July 2013 - 12:54 PM

Investing In Stem Cell Technology: An Interview With Dr. Michael West, Biotime ...
Seeking Alpha - Jul 16, 2013
Dr. West is the Chief Executive Officer of BioTime. Prior to BTX Dr. West served as Chief Executive Officer, President, and Chief Scientific Officer of Advanced Cell Technology, Inc. (ACTC.OB). He also founded another well-known biotech company, Geron ...

View the full article

#285 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 18 July 2013 - 01:05 PM

BIOTIME, INC. : BioTime Subsidiary LifeMap Sciences Announces Publication of ...
4-traders (press release) - 3 hours ago
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that the LifeMap Discovery? product has been documented in a published paper authored by LifeMap Sciences' research and development team.

View the full article

#286 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 18 July 2013 - 11:00 PM

BioTime Subsidiary LifeMap Sciences Announces Publication of Research ...
DailyFinance - 7 hours ago
(BUSINESS WIRE)-- LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that the LifeMap Discoveryâ„¢ product has been documented in a published paper authored by LifeMap Sciences' research and development team.

View the full article

#287 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 19 July 2013 - 12:25 AM

Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Presents at Prestigious ...
PR Web (press release) - Jul 19, 2013
The CEOs of OSIRIS, BioTime, Mesoblast and the Directors of the Harvard Stem Cell Institute, and Genetics Policy Institute, along with many other global leaders also spoke.

View the full article

#288 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 16 July 2013 - 01:20 PM

Investing In Stem Cell Technology: An Interview With Dr. Michael West, Biotime ...
Seeking Alpha - Jul 16, 2013
Dr. West is the Chief Executive Officer of BioTime. Prior to BTX Dr. West served as Chief Executive Officer, President, and Chief Scientific Officer of Advanced Cell Technology, Inc. (ACTC.OB). He also founded another well-known biotech company, Geron ...

View the full article

#289 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 26 July 2013 - 01:24 PM

BIOTIME, INC. : LifeMap Sciences Announces Release of LifeMap DiscoveryTM ...
4-traders (press release) - 22 minutes ago
BioTime, Inc. : LifeMap Sciences Announces Release of LifeMap DiscoveryTM Version 1.2 with Extensive Stem Cell Therapy Data.

View the full article

#290 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 29 July 2013 - 04:17 AM

BioTime Subsidiary LifeMap Sciences Publishes Research Report Describing ...
HispanicBusiness.com - 29 minutes ago
LifeMap Sciences, Inc. , a subsidiary of BioTime, Inc. , announced that the LifeMap Discovery product has been documented in a published paper authored by LifeMap Sciences' research and development team.

View the full article

#291 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 05 August 2013 - 02:25 PM

BIOTIME, INC. : BioTime's Subsidiary OncoCyte Corporation Publishes Data on ...
4-traders (press release) - 14 hours ago
5, 2013-- BioTime, Inc. (NYSE MKT: BTX) and BioTime's subsidiary OncoCyte Corporation today announced the publication of a scientific report on the gene FSIP1 and its potential as a marker for breast cancer.

View the full article

#292 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 05 August 2013 - 09:55 PM

BioTime's Subsidiary OncoCyte Corporation Publishes Data on the Gene FSIP1 ...
DailyFinance - 14 hours ago
(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX) and BioTime's subsidiary OncoCyte Corporation today announced the publication of a scientific report on the gene FSIP1 and its potential as a marker for breast cancer.

View the full article

#293 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 06 August 2013 - 02:45 PM

BIOTIME, INC. : LifeMap Sciences, a Subsidiary of BioTime, Announces Release ...
4-traders (press release) - 1 hour ago
ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the release of MalaCards, Version 1.04.

View the full article

#294 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 06 August 2013 - 06:36 PM

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of MalaCards ...
PharmiWeb.com (press release) - Aug 6, 2013
LifeMap Sciences Inc. a subsidiary of BioTime Inc. announced today the release of MalaCards Version 1.04. The new release is available at http://www.

View the full article

#295 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 08 August 2013 - 10:01 PM

PDL BIOPHARMA INC. : PDL BioPharma Announces Second Quarter 2013 ...
4-traders (press release) - 1 hour ago
He joins PDL from BioTime, Inc. (NYSE MKT: BTX) where he served as CFO since 2011. Mr. Montez, who is a licensed certified public accountant, brings more than 13 years of experience overseeing accounting and financial functions and most recently ...

View the full article

#296 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 09 August 2013 - 08:11 PM

BIOTIME, INC. : BioTime Announces Second Quarter 2013 Financial Results ...
4-traders (press release) - 35 minutes ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the second quarter ended June 30, 2013 and highlighted recent corporate ...

View the full article

#297 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 10 August 2013 - 01:39 AM

BioTime loses $7.5 million in June quarter
San Francisco Business Times (blog) - 2 hours ago
BioTime Inc. lost $7.5 million in the second quarter ended June. That's up from a loss of $5.5 million a year earlier. The Alameda company had revenue of $1.2 million during the June quarter, up from revenue of $1 million a year earlier.

View the full article

#298 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 09 August 2013 - 08:22 PM

BioTime Announces Second Quarter 2013 Financial Results and Recent ...
The Herald | HeraldOnline.com - 10 hours ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the second quarter ended June 30, 2013 and highlighted recent corporate ...

View the full article

#299 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 11 August 2013 - 04:42 PM

PDL BioPharma Announces Second Quarter 2013 Financial Results
PR-BG.com (прессъобщения) (press release) - 8 hours ago
He joins PDL from BioTime, Inc. (NYSE MKT: BTX) where he served as CFO since 2011. Mr. Montez, who is a licensed certified public accountant, brings more than 13 years of experience overseeing accounting and financial functions and most recently ...

View the full article

#300 ImmInst

  • Admin, Director robot
  • 2,357 posts
  • 73 ₮

Posted 15 August 2013 - 10:08 AM

Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the ...
PR Web (press release) - 3 hours ago
Robert J. Harman, DVM, Chief Executive Officer of Vet-Stem, Inc., a leading Regenerative Veterinary Medicine company located in San Diego, California, has been invited back to speak at the Adult Stem Cell Therapy and Regenerative Medicine Conference ...

View the full article
Back to Ventures & Markets



Also tagged with one or more of these keywords: economics, regenerative medicine, stemells, tissue engineering, regmed

21 user(s) are reading this topic

0 members, 21 guests, 0 anonymous users

  1. LONGECITY
  2. → Round Table Discussion
  3. → Business
  4. → Ventures & Markets
  5. site rules